CX NEWS
CX 2019: A Latin American perspective in vascular and endovascular surgery
Alberto Muñoz (Bogota, Colombia) talks to BLearning at CX 2019 (Charing Cross Symposium; 15–18 April, London, UK) about how the meeting provides a “great opportunity” to update attendees on the latest in vascular and endovascular surgery. Muñoz goes [...]
CX 2019: Experts discuss latest findings from the STEP study
Roger Greenhalgh (London, UK) is joined by Fiona Rohlffs (Hamburg, Germany), Tilo Kölbel (Hamburg, Germany) and Heinz Jakob (Essen, Germany) to discuss the latest findings of the Stroke from Thoracic Endovascular Procedures (STEP) study [...]
Type II endoleak with secondary sac expansion remains elusive
Leading experts including Robert Morgan (London, UK), Richard McWilliams (Liverpool, UK), Stéphan Haulon (Paris, France), Tilo Kölbel (Hamburg, Germany) and Peter Schneider (Honolulu, USA) discuss the various approaches to correcting endoleak during CX 2018 [...]
CX 2019: VBX set to be a “game-changer” for treating complex aortic aneurysms
Giovanni Torsello (Münster, Germany) and Mauro Gargiulo (Bologna, Italy) discuss the “very high” morbidity and mortality caused by open surgery when treating complex aortic aneurysms. This is why, they say, the use of fenestrated [...]
MDR will be “the most devastating thing to happen to European healthcare since WW2”
Speaking at the Charing Cross Symposium 2019, Jeffrey Jump (Nyon, Switzerland), outlines the impact of the Medical Device Regulations (MDR), which he believes will be “the most devastating thing to happen to European healthcare [...]
Intra-arterial calcification poses “one of the biggest challenges” for endovascular therapy
Andrew Holden (Auckland, New Zealand) provides perspective on the first results from the Disrupt PAD III observational registry that were presented at the Charing Cross International Symposium 2019. This large registry is designed to [...]